McKesson Corporation (MCK) — Business segments and KPIs
Revenue by business segment and geography for McKesson Corporation, with year-over-year trends.
FY 2026
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| North American Pharmaceutical Segment | 336.65B | 83.4% |
| Oncology And Multispecialty Segment | 48.42B | 12.0% |
| Medical-Surgical Solutions Segment | 11.51B | 2.9% |
| Prescription Technology Solutions Segment | 5.81B | 1.4% |
| Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment | 1.04B | 0.3% |
| Revenue by region | ||
| UNITED STATES | 192.71B | 83.4% |
| International Segment | 38.34B | 16.6% |